Covered recipient · General Payments record
DARIUS R MEHREGAN
Allopathic & Osteopathic Physicians Dermatology Dermatopathology
General Payments · PY2018–2024
$3,624.27
- Reported across 28 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,600.00 | 1 |
| Food and Beverage | $320.05 | 7 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $2,600.00 | 1 |
| ABBVIE INC. | $159.77 | 3 |
| Lilly USA, LLC | $85.43 | 1 |
| Janssen Scientific Affairs, LLC | $27.15 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.27 | 1 |
| Helsinn Therapeutics (U.S.), Inc. | $21.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.59 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105015420 | CMS |
| ABBVIE INC. | $18.18 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105015422 | CMS |
| ABBVIE INC. | $125.00 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105015424 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.27 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118033635 | CMS |
| Helsinn Therapeutics (U.S.), Inc. | $21.43 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134567699 | CMS |
| Janssen Scientific Affairs, LLC | $27.15 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078852594 | CMS |
| Lilly USA, LLC | $85.43 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136125719 | CMS |
| UCB, Inc. | $2,600.00 | 09/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1143101607 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.